NDC 50844-197 - Aspirin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50844-197
- Package NDCs from labels
- 50844-197-12
- Manufacturer
- L.N.K. International, Inc. | LNK International, Inc.
- Effective date
- 2019-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Quality Plus 44-157-NI-Delisted | L.N.K. International, Inc. | LNK International, Inc. | 2019-08-14 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | 6DC9Q167V3 |
| ORPHENGESIC FORTE | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Galt Pharmaceuticals, LLC | 5bc485db-9d96-4291-aaa3-2a96ebf3098a | 2025-10-16 | Warnings, Adverse reactions | R16CO5Y76E |
| Alka-Seltzer Hangover Relief | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | dc235b06-999e-221d-e053-2a95a90a0ce1 | 2025-10-16 | Warnings | R16CO5Y76E |
| Orphenadrine Citrate, Aspirin and Caffeine | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Atland Pharmaceuticals, LLC | 61ca2af1-081c-411c-90ce-ec6d9e3157b2 | 2025-10-16 | Warnings, Adverse reactions | R16CO5Y76E |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 41386de5-5857-efab-e063-6294a90afd9c | 2025-10-15 | Warnings | R16CO5Y76E |
| Aspirin 81mg | ASPIRIN ENTERIC COATED TABLETS 81MG | VITANE PHARMACEUTICALS, INC | 4138d4c0-baa5-1f20-e063-6394a90a788f | 2025-10-15 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreens | f2eb9575-d527-44c7-aa5e-efabfd9a0278 | 2025-10-07 | Warnings | R16CO5Y76E |
| Aspirin Enteric Coated | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | f1ce15a3-9824-4eb5-910a-39078165f385 | 2025-10-07 | Warnings | R16CO5Y76E |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Rising Pharma Holdings, Inc. | 50f72713-50f5-4bab-9e96-b9fa73c9df1f | 2025-10-06 | Warnings | R16CO5Y76E |
| Chewable Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | cc865351-34e8-4e8e-b8bf-23336c45bc61 | 2025-10-02 | Warnings | R16CO5Y76E |
| ASPIRIN 325 MG EC | ASPIRIN | Proficient Rx LP | 9f9355f7-024a-4adc-bb4c-2d9c0dd0cb77 | 2025-10-01 | Warnings | R16CO5Y76E |
| ASPIRIN | ASPIRIN | Marc Glassman, Inc. | 14cb1d2d-95b8-447e-8d79-e6ec82c0e431 | 2025-10-01 | Warnings | R16CO5Y76E |
| Enteric Coated Aspirin Regular Strength | ASPIRIN | Bryant Ranch Prepack | e05140fa-9766-4f97-bffc-e36a01b9d38f | 2025-10-01 | Warnings | R16CO5Y76E |
| First Aid Direct Chewable Aspirin | ASPIRIN | Cintas Corp | ff6960f6-9f55-4f32-9ab5-9187724531e9 | 2025-09-25 | Warnings | R16CO5Y76E |
| Bayer Rapid Relief Body Pain | ASPIRIN/CAFFEINE ORAL POWDER | Bayer HealthCare LLC. | 3fa1ec07-d1a6-226b-e063-6394a90a3213 | 2025-09-25 | Warnings | R16CO5Y76E |
| Xpect Chewable Aspirin | ASPIRIN | Cintas Corporation | bddce374-1d35-4685-987d-4a4cc9994155 | 2025-09-25 | Warnings | R16CO5Y76E |
| Xpect Pain Away Extra Strength | ACETAMINOPHEN ASPIRIN CAFFEINE | Cintas Corporation | 1269d069-afaf-4ca5-b369-f74249a348db | 2025-09-24 | Warnings | R16CO5Y76E |
| Aspirin Low Dose | ASPIRIN | Preferred Pharmaceuticals Inc. | 29214eec-860c-43f0-83c6-9ed5a9f530af | 2025-09-22 | Warnings | R16CO5Y76E |
| ASPIRIN | ASPIRIN | Kroger Company | bbee8ee4-e09d-3ba6-e053-2a95a90af647 | 2025-09-19 | Warnings | R16CO5Y76E |
| migraine formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | H E B | f2f9b930-7b54-46c5-8631-d673a52a9eb4 | 2025-09-19 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.